These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Is it possible to obtain a reduction of body weight exclusively via a loss in fat mass? Experience with d-fenfluramine]. Del Ponte A; D'Orazio N; Di Giacomo G; Tritella T; Bitti G; Martines G Recenti Prog Med; 1993 Feb; 84(2):100-5. PubMed ID: 8465086 [TBL] [Abstract][Full Text] [Related]
45. Hormone ontogeny in the ovine fetus and neonate. XXII. The effect of somatostatin on the growth hormone (GH) response to GH-releasing factor. de Zegher F; Daaboul J; Grumbach MM; Kaplan SL Endocrinology; 1989 Mar; 124(3):1114-7. PubMed ID: 2563681 [TBL] [Abstract][Full Text] [Related]
46. Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects. Lee EJ; Nam SY; Kim KR; Lee HC; Cho JH; Nam MS; Song YD; Lim SK; Huh KB J Clin Endocrinol Metab; 1995 Aug; 80(8):2495-8. PubMed ID: 7629249 [TBL] [Abstract][Full Text] [Related]
47. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. Cordido F; Peñalva A; Dieguez C; Casanueva FF J Clin Endocrinol Metab; 1993 Apr; 76(4):819-23. PubMed ID: 8473389 [TBL] [Abstract][Full Text] [Related]
48. Effect of human growth hormone-releasing factor and(or) thyrotropin-releasing factor on hormone concentrations in dairy calves. Lapierre H; Petitclerc D; Pelletier G; Delorme L; Dubreuil P; Morisset J; Gaudreau P; Couture Y; Brazeau P J Anim Sci; 1990 Aug; 68(8):2436-49. PubMed ID: 2119375 [TBL] [Abstract][Full Text] [Related]
49. Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity. Ghigo E; Procopio M; Boffano GM; Arvat E; Valente F; Maccario M; Mazza E; Camanni F Metabolism; 1992 May; 41(5):560-3. PubMed ID: 1588839 [TBL] [Abstract][Full Text] [Related]
50. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects. Kelijman M; Frohman LA J Clin Endocrinol Metab; 1988 Mar; 66(3):489-94. PubMed ID: 3127415 [TBL] [Abstract][Full Text] [Related]
51. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition. Snyder DK; Clemmons DR; Underwood LE J Clin Endocrinol Metab; 1988 Jul; 67(1):54-61. PubMed ID: 3379136 [TBL] [Abstract][Full Text] [Related]
52. Post-somatostatin rebound secretion of growth hormone is dependent on growth hormone-releasing factor in unrestrained female rats. Sugihara H; Minami S; Wakabayashi I J Endocrinol; 1989 Aug; 122(2):583-91. PubMed ID: 2570118 [TBL] [Abstract][Full Text] [Related]
53. Long-term alterations in growth hormone and insulin secretion after temporary dietary protein restriction in early life in the rat. Harel Z; Tannenbaum GS Pediatr Res; 1995 Nov; 38(5):747-53. PubMed ID: 8552444 [TBL] [Abstract][Full Text] [Related]